Zaid S Al-Kadhimi MD
Hematologic Oncology
Director of the Blood and Marrow Transplantation and Cell Therapy Program (BMT) in the UAB Heersink School of Medicine’s Division of Hematology & Oncology.
Request appointment
2000 6th Avenue SouthFloor 5Birmingham, AL 35233
Overview of Dr. Al-Kadhimi
Dr. Zaid Al-Kadhimi is an oncologist in Birmingham, AL and is affiliated with University of Alabama Hospital. He received his medical degree from University of Baghdad College of Medicine and has been in practice 35 years. Dr. Al-Kadhimi accepts several types of health insurance, listed below. He is one of 82 doctors at University of Alabama Hospital who specialize in Oncology. He has more than 60 publications and over 500 citings.
Clinical Expertise
- Hematologic oncology, Myeloproliferative disease, Stem cell transplantation, Graft-versus-host disease, Neonatal respiratory syncytial virus infection, Pain measurement, Incision site infection, Hematopoietic stem cell transplantation, Transplantation conditioning, Oropharyngeal lymphoma
Education & Training
City of Hope National Medical CenterFellowship, Hematology and Medical Oncology, 1998 - 2021- City of Hope Comprehensive Cancer CenterFellowship, Tumor Immunology research fellowship K 12 NIH award, 2002 - 2007
- City of Hope National Medical CenterFellowship, Blood & Bone Marrow Transplant, 2001 - 2003
Henry Ford Health/Henry Ford HospitalResidency, Internal Medicine, 1994 - 1997
University of Baghdad College of MedicineClass of 1991
Certifications & Licensure
CA State Medical License 1998 - Present
AL State Medical License 2022 - 2026
NE State Medical License 2018 - 2026
GA State Medical License 2013 - 2018
MI State Medical License 1996 - 2014
RI State Medical License 2007 - 2014
ND State Medical License 1997 - 1998
American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification PowerChart (Clinical), Cerner Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification HealtheLife and PowerChart, Cerner Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification Cerner Patient Portal and Powerchart, Cerner Corporation, 2014, 2016-2017
Clinical Trials
- Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant
- Laboratory-Treated T Cells After Second-Line Chemotherapy in Treating Patients With HER2/Neu-Negative Metastatic Breast Cancer Start of enrollment: 2010 Mar 08
- Targeted T Cells After Neoadjuvant Chemotherapy in Treating Women With Stage II or III Breast Cancer Undergoing Surgery
Publications & Presentations
PubMed
- 16 citationsRandomized Phase III SIERRA Trial ofI-Apamistamab Before Allogeneic Hematopoietic Cell Transplantation Versus Conventional Care for Relapsed/Refractory AML.Boglarka Gyurkocza, Rajneesh Nath, Stuart Seropian, Hannah Choe, Mark R Litzow
Journal of Clinical Oncology. 2025-01-10 - 2 citationsIdarubicin and cytarabine with and without midostaurin for FLT3-mutated acute myeloid leukemia.Kendall Diebold, Garrett Bourne, Manuel Espinoza-Gutarra, Zaid Al-Kadhimi, Kimo Bachiashvili
Leukemia & Lymphoma. 2024-11-01 - 6 citationsLow-dose decitabine plus venetoclax as post-transplant maintenance for high-risk myeloid malignancies.Katherine Parks, Kendall Diebold, Donna Salzman, Antonio Di Stasi, Zaid Al-Kadhimi
Ejhaem. 2024-06-01
Abstracts/Posters
- Integrating Geriatric Assessment and Genetic Profiling to Personalize Therapy Selection in Older Adults with Acute Myeloid Leukemia (AML)Zaid S. Al-Kadhimi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- The Effect of Age and CD34+ Stem Cell Dose on Autologous Hematopoietic Stem Cell Transplantation Outcomes in Multiple Myeloma _ Single Institution ExperienceZaid S. Al-Kadhimi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Effect of Using Multiagent Versus Single Agent Chemotherapy on Overall Survival (OS) of Older Adults with Acute Myeloid Leukemia (AML)Zaid S. Al-Kadhimi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Illinois PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Cofinity PPO
Empire BCBS HMO
Empire BCBS PPO
First Health PPOGreat West PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
PriorityHealth HMO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: